Shawn Zinnen

Shawn Zinnen is the current CEO of MBC Pharma. Shawn has over 25 years of experience in the pharmaceutical industry, holding positions of increasing responsibility. Most recently, they served as Director of Biochemistry at Sirna Therapeutics from 1997 to 2005. Shawn has a deep understanding of the drug discovery process and has been instrumental in the development of several successful commercial drugs. Shawn has a passion for helping people and improving patient outcomes, which drives him in their work at MBC Pharma.

Shawn Zinnen received a BS in molecular biology and music performance from the University of Wisconsin-Madison. Shawn then went on to earn a PhD in biochemistry, enzymology, and genetics from Duke University.

A direct report to Shawn Zinnen is and Alexander Karpeisky - President & Chief Scientific Officer.